Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Expression and Functional Properties of NMDA and GABAA Receptors during Differentiation of Human Induced Pluripotent Stem Cells into Ventral Mesencephalic Neurons.

Antonov SA, Novosadova EV, Kobylyansky AG, Illarioshkin SN, Tarantul VZ, Grivennikov IA.

Biochemistry (Mosc). 2019 Mar;84(3):310-320. doi: 10.1134/S0006297919030131.

PMID:
31221069
2.

A Platform for Studying Neurodegeneration Mechanisms Using Genetically Encoded Biosensors.

Ustyantseva EI, Medvedev SP, Vetchinova AS, Minina JM, Illarioshkin SN, Zakian SM.

Biochemistry (Mosc). 2019 Mar;84(3):299-309. doi: 10.1134/S000629791903012X.

PMID:
31221068
3.

[A comparative analysis of allele frequencies of rs1801133 and rs1801131 of MTHFR in patients with stroke and healthy people from the Moscow region].

Dribnokhodova OP, Korchagin VI, Mironov KO, Dunaeva EA, Titkov AV, Akselrod EV, Raskurazhev AA, Tanashyan MM, Illarioshkin SN, Platonov AE, Shipulin GA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(3. Vyp. 2):18-23. doi: 10.17116/jnevro201911903218. Russian.

PMID:
31184621
4.

Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.

Grigor'eva EV, Malankhanova TB, Surumbayeva A, Minina JM, Morozov VV, Abramycheva NY, Illarioshkin SN, Malakhova AA, Zakian SM.

Stem Cell Res. 2019 Jan;34:101382. doi: 10.1016/j.scr.2018.101382. Epub 2019 Jan 2.

5.

Genetic Association between Alzheimer's Disease Risk Variant of the PICALM Gene and Auditory Event-Related Potentials in Aging.

Ponomareva NV, Andreeva TV, Protasova MA, Filippova YV, Kolesnikova EP, Fokin VF, Illarioshkin SN, Rogaev EI.

Biochemistry (Mosc). 2018 Sep;83(9):1075-1082. doi: 10.1134/S0006297918090092.

6.

Genome Editing and the Problem of Tetraploidy in Cell Modeling of the Genetic Form of Parkinsonism.

Simonova VV, Vetchinova AS, Novosadova EV, Khaspekov LG, Illarioshkin SN.

Biochemistry (Mosc). 2018 Sep;83(9):1040-1045. doi: 10.1134/S0006297918090055. Review.

7.

Molecular Pathogenesis in Huntington's Disease.

Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV.

Biochemistry (Mosc). 2018 Sep;83(9):1030-1039. doi: 10.1134/S0006297918090043. Review.

8.

Cytogenetic Analysis of the Results of Genome Editing on the Cell Model of Parkinson's Disease.

Vetchinova AS, Simonova VV, Novosadova EV, Manuilova ES, Nenasheva VV, Tarantul VZ, Grivennikov IA, Khaspekov LG, Illarioshkin SN.

Bull Exp Biol Med. 2018 Jul;165(3):378-381. doi: 10.1007/s10517-018-4174-y. Epub 2018 Jul 13.

PMID:
30006877
9.

Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson's Disease.

Shulskaya MV, Alieva AK, Vlasov IN, Zyrin VV, Fedotova EY, Abramycheva NY, Usenko TS, Yakimovsky AF, Emelyanov AK, Pchelina SN, Illarioshkin SN, Slominsky PA, Shadrina MI.

Front Aging Neurosci. 2018 May 15;10:136. doi: 10.3389/fnagi.2018.00136. eCollection 2018.

10.

[Complex assessment of the contribution of genetic factors to the risk of ischemic stroke].

Korchagin VI, Mironov KO, Platonov AE, Dribnokhodova OP, Akselrod EV, Dunaeva EA, Raskurazhev AA, Tanashyan MM, Maksimova MY, Illarioshkin SN, Shipulin GA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12. Vyp. 2):11-18. doi: 10.17116/jnevro201711712211-18. Russian.

PMID:
29411740
11.

Neuroprotective Properties of Endocannabinoids N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine Examined in Neuronal Precursors Derived from Human Pluripotent Stem Cells.

Novosadova EV, Arsenyeva EL, Manuilova ES, Khaspekov LG, Bobrov MY, Bezuglov VV, Illarioshkin SN, Grivennikov IA.

Biochemistry (Mosc). 2017 Nov;82(11):1367-1372. doi: 10.1134/S0006297917110141.

PMID:
29223163
12.

Expression of Type I Cannabinoid Receptors at Different Stages of Neuronal Differentiation of Human Fibroblasts.

Bobrov MY, Bezuglov VV, Khaspekov LG, Illarioshkin SN, Novosadova EV, Grivennikov IA.

Bull Exp Biol Med. 2017 Jun;163(2):272-275. doi: 10.1007/s10517-017-3782-2. Epub 2017 Jul 21.

PMID:
28730390
13.

Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism.

Slominsky PA, Shadrina MI, Kolomin TA, Stavrovskaya AV, Filatova EV, Andreeva LA, Illarioshkin SN, Myasoedov NF.

Dokl Biol Sci. 2017 May;474(1):106-109. doi: 10.1134/S0012496617030048. Epub 2017 Jul 13.

PMID:
28702721
14.

A 30-year history of MPAN case from Russia.

Selikhova M, Fedotova E, Wiethoff S, Schottlaender LV, Klyushnikov S, Illarioshkin SN, Houlden H.

Clin Neurol Neurosurg. 2017 Aug;159:111-113. doi: 10.1016/j.clineuro.2017.05.025. Epub 2017 Jun 2.

PMID:
28641177
15.

[Differential diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy].

Moroz AA, Abramycheva NY, Stepanova MS, Konovalov RN, Timerbaeva SL, Illarioshkin SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(4):75-80. doi: 10.17116/jnevro20171174175-80. Russian.

PMID:
28617385
16.

[Levodopa-carbidopa intestinal gel in the treatment of patients with Parkinson disease: results of a 12-month open study].

Skoromets AA, Odinak MM, Yakupov EZ, Litvinenko IV, Zalyalova ZA, Timofeeva AA, Kirtaev SY, Bogdanov RR, Agafina AS, Chatamra K, Robieson W, Benesh J, Latypova GR, Ershova MV, Illarioshkin SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2):22-31. doi: 10.17116/jnevro20171172122-31. Russian.

PMID:
28374689
17.

Quantitative EEG during normal aging: association with the Alzheimer's disease genetic risk variant in PICALM gene.

Ponomareva NV, Andreeva TV, Protasova MS, Shagam LI, Malina DD, Goltsov AY, Fokin VF, Illarioshkin SN, Rogaev EI.

Neurobiol Aging. 2017 Mar;51:177.e1-177.e8. doi: 10.1016/j.neurobiolaging.2016.12.010. Epub 2016 Dec 20.

18.

Investigation of the effects of GABA receptor agonists in the differentiation of human induced pluripotent stem cells into dopaminergic neurons.

Antonov SA, Novosadova EV, Arsenyeva EL, Grefenstein MA, Zykova AA, Kobylyansky AG, Manuilova ES, Grivennikov IA, Illarioshkin SN, Myasoedov NF.

Dokl Biol Sci. 2016 Sep;470(1):244-246. Epub 2016 Nov 8.

PMID:
27822752
19.

Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.

Shulskaya MV, Shadrina MI, Fedotova EY, Abramycheva NY, Limborska SA, Illarioshkin SN, Slominsky PA.

Int J Neurosci. 2017 Sep;127(9):781-784. doi: 10.1080/00207454.2016.1255612. Epub 2016 Nov 16.

PMID:
27798970
20.

[Characteristics of Parkinson's disease course in the heterozygous carriage of mutations in the glucocerebrosidase A gene].

Gan'kina OA, Vasenina EE, Levin OS, Fedotova EY, Illarioshkin SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(6):71-76. Russian.

PMID:
27723713

Supplemental Content

Loading ...
Support Center